Neurofibromatosis and Tuberous Sclerosis

Published on 05/03/2015 by admin

Filed under Dermatology

Last modified 05/03/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 4805 times

50

Neurofibromatosis and Tuberous Sclerosis

Neurofibromatosis Type 1 (von Recklinghausen Disease)

Incidence of approximately 1 in 3000 births.

The NF1 tumor suppressor gene encodes the neurofibromin protein, which negatively regulates the RAS-mitogen-activated protein kinase (MAPK) pathway that promotes cell survival and proliferation.

Patients with NF1 have a constitutive (germline) NF1 mutation plus a somatic ‘second hit’ mutation inactivating the other copy of the gene in affected tissues (e.g. Schwann cells in neurofibromas, melanocytes in café-au-lait macules [CALMs]).

The major clinical features of NF1 are outlined in Table 50.1 and depicted in Figs. 50.150.5; Fig. 50.6 shows the time course of their development.